Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
115.50    0.00 (0.00%)
Bid:
116.00
Ask:
118.00
Spread: 2.00 (1.724%)
Market Cap: £255.31m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Update re Financing Facility

28 Nov 2008 07:00

RNS Number : 1381J
Queen's Walk Investment Limited
28 November 2008
 



Update on QWIL's Financing Facility

As at 27 November 2008, the Company had drawn €40.5 million against its financing facility and had undrawn availability of €94.5 million. Given current market yields, the Company should be able to achieve its return objectives on new investments without the need for additional leverage. In addition, in today's highly volatile markets, the Company could have been exposed to material change clauses that might have triggered the requirement for the repayment of the facility on unfavourable terms.

In light of these circumstances, the Company has successfully negotiated amended terms on a reduced facility, involving a flexible two year repayment schedule of the outstanding debt and has reduced the risk associated with material change clauses that could have forced a repayment of the debt on unfavourable terms. The Company's cash balance of €16.5 million as at 27 November 2008 and continued cash flows from its investment portfolio support the repayment schedule and the timely redemption of the loan facility. The Company believes that the renegotiated loan facility is more prudent than continued dependence on an unpredictable lending market.

The Company has completed negotiations with its lender and the key elements of the amended facility are summarised below.

The Company has committed to repay the outstanding balance of the facility by October 2011, pursuant to an agreed loan amortisation schedule and will not make any further draw downs. The Company believes it should be able to satisfy the loan amortisation schedule with the €16.5 million of cash currently on the balance sheet and the expected cash flows from its investment portfolio. In addition, at the end of each quarter, the Company has pledged to keep the outstanding balance of the financing facility below the product of the then applicable advance rate ("Applicable Percentage") and the value of the investment portfolio plus cash (the "Borrowing Base"). At present, the Company's Borrowing Base is approximately €62.9 million versus a loan balance of €40.5 million

At the end of each calendar quarter, the Company has agreed a target loan amount ("Target Loan Amount") with the lenders. The Company has also agreed to an Applicable Percentage for every quarter. The Target Loan Amount and Applicable Percentage Schedule are detailed below:

Date

Target Loan Amount

Applicable Percentage for Residuals

31 December 2008

35,000,000

30%

31 March 2009 

33,000,000

30%

30 June 2009 

31,000,000

30%

30 September 2009

28,500,000

30%

31 December 2009

27,000,000

27.5%

31 March 2010 

25,000,000

20%

30 June 2010

12,000,000

20%

30 September 2010

10,000,000

20%

31 December 2010

0

20%

31 March 2011

0

10%

The Applicable Percentage for the Company's investment grade bond portfolio will be 50%, 40%, 30% and 15% for AA and above, A and above, BBB and above and BB and above; rated bonds respectively.

The Target Loan Amount will reduce by €11 million in the event that the Magellan 1 transaction is re-financed by the originator, BCP Millennium, before June 2010. The Applicable Percentage for residuals will reduce to 25% if the Magellan 1 transaction is re-financed by BCP Millennium before 31 December 2009.

The Company has committed to use a percentage of its Free Cash (cash proceeds in a quarter less dividends and operating expenses) to amortise the facility. Prior to the Magellan 1 transaction being refinanced, 75% of the Company's Free Cash will be used to repay the facility. After the Magellan 1 transaction is called, 66% of the Free Cash will be used to repay the debt. Once the outstanding balance of the facility is below €22 million, 50% of the Free Cash will be used to repay the facility. If the outstanding balance of the loan facility is less than the Target Loan Amount on the relevant date, the dividend will be capped at €2.25 million per quarter (or approximately a 19% dividend yield on the share price as at 26 November 2008). If the Company is unable to satisfy the loan amortisation schedule, the dividend will be capped at 8% on the share price prevailing at the end of each quarter. A failure to meet the loan amortisation schedule would not trigger an event of default.

In the event that the balance of the facility is greater than the Borrowing Base, the Company will have 20 business days to remedy the breach. Failure to remedy the breach would constitute an event of default. 

The Company has agreed to more asset specific tests in exchange for limiting the scope of the material change triggers and believes that the investment portfolio can support the amended facility.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZGMZMFNMGRZZ
Date   Source Headline
11th Nov 20207:00 amRNSFact Sheet Announcement
28th Oct 20207:00 amRNSInvestment Manager Q2 Investor Presentation
9th Oct 20207:00 amRNSFact Sheet Announcement
22nd Sep 20204:30 pmRNSNotification of Major Interest in Shares
17th Sep 20204:30 pmRNSResult of AGM
14th Sep 20207:15 amEQSHardman & Co Research: Real Estate Credit Investments (RECI): Improving returns on new opportunities
8th Sep 20207:00 amRNSFact Sheet Announcement
17th Aug 20207:00 amRNSInvestment Manager Q1 Investor Presentation
14th Aug 20207:00 amRNSNotice of AGM
7th Aug 20207:00 amRNSFact Sheet Announcement
6th Aug 20207:00 amRNSDividend Declaration
7th Jul 20207:00 amRNSFact Sheet Announcement
30th Jun 20207:30 amEQSHardman & Co Research: Q&A with Mark Thomas on Real Estate Credit Investments (RECI): Getting a balanced view on outlook
26th Jun 20205:01 pmRNSPublication of Supplementary Prospectus
26th Jun 202010:53 amRNSAnnual Financial Report
25th Jun 20207:00 amRNSAnnual Financial Report
5th Jun 20207:00 amRNSFact Sheet Announcement
22nd May 20204:07 pmRNSDirector/PDMR Shareholding
21st May 20207:30 amEQSHardman & Co Research: Real Estate Credit Investments (RECI): Getting a balanced view on outlook
15th May 20207:00 amRNSDividend Declaration & Company Update Presentation
12th May 20207:00 amRNSFact Sheet Announcement
27th Apr 20204:38 pmRNSDisclosure of Rights Attached to Equity Shares
27th Apr 202010:39 amRNSDirector/PDMR Shareholding
23rd Apr 202012:13 pmRNSDirector/PDMR Shareholding
21st Apr 20205:42 pmRNSDirector/PDMR Shareholding
9th Apr 20204:38 pmRNSDirector/PDMR Shareholding
9th Apr 20202:29 pmRNSDirector/PDMR Shareholding
9th Apr 20207:00 amRNSFact Sheet Announcement
25th Mar 20204:14 pmRNSDirector/PDMR Shareholding
25th Mar 202012:08 pmRNSSecond Price Monitoring Extn
25th Mar 202012:02 pmRNSPrice Monitoring Extension
20th Mar 20207:00 amRNSMarket Update
10th Mar 20204:57 pmRNSDirector/PDMR Shareholding
10th Mar 20203:00 pmRNSResult of EGM
9th Mar 20207:00 amRNSFact Sheet Announcement
28th Feb 20207:00 amRNSTotal Voting Rights
25th Feb 202011:00 amRNSDirector/PDMR Shareholding
24th Feb 202012:15 pmRNSDirector/PDMR Shareholding
21st Feb 20203:26 pmRNSDividend Declaration
21st Feb 20202:46 pmRNSPublication of a Prospectus
13th Feb 20207:00 amRNSProposed Placing Programme and Notice of EGM
7th Feb 20207:00 amRNSFact Sheet Announcement
4th Feb 20209:17 amRNSClose of Issue of New Ordinary Shares
30th Jan 20207:00 amRNSProposed Issue of New Ordinary Shares
24th Jan 20207:00 amRNSInvestment Manager Q3 Investor Presentation
20th Jan 20207:00 amRNSPress Release - RECI commits over £105m in Dec 19
10th Jan 20207:00 amRNSFact Sheet Announcement
17th Dec 20191:06 pmEQSHardman & Co Research: Real Estate Credit Investments (RECI): Delivering on its promises
10th Dec 20197:00 amRNSFact Sheet Announcement
29th Nov 20197:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.